SB220025 - CAS 165806-53-1

SB220025 is an orally available, selective and potent inhibitor of P38 mitogen-activated protein kinase that inhibits p56Lck and PKC, inhibits endothelial growth hormone-induced Ca (2+) signaling, and inhibits angiogenesis, and can be used in the study of arthritis.

Src, p38 MAPK, PKC

MAPK, Cytoskeletal Signaling, Tyrosine Kinase/Adaptors, Chromatin/Epigenetic, Angiogenesis

165752

0.9944

C18H19FN6

338.38

FC1=CC=C(C=C1)C=2N=CN(C2C=3N=C(N=CC3)N)C4CCNCC4

-20°C

Ice Packs

Small Compound